Oculus Innovative Sciences has enrolled first patient, under an FDA-reviewed protocol, in a clinical study of its Microcyn hydrogel. Microcyn hydrogel is indicated for use in hypertrophic or keloid scars management. The double-blind, ...
Tags: Oculus Innovative Sciences, Microcyn hydrogel, keloid scars management
The Chinese State Food and Drug Administration (SFDA) has granted approval to Oculus Innovative Sciences' Microcyn hydrogel for moistening, repairing and healing acute and chronic wounds. The approval is based on the completion of ...
Tags: SFDA, Oculus Microcyn Hydrogel, healing acute, chronic wounds